Clin2
NCT06901570Worth exploringNot yet recruiting

Aromatic Wentong herbal medicine for coronary microvascular disease

Coronary Microvascular Disease

Part of Heart & circulation clinical trials.

This study tests a Chinese herbal medicine called Aromatic Wentong to see if it can improve blood flow to the heart muscle in people with coronary microvascular disease — a condition where the heart's smallest blood vessels don't work well, causing chest pain. The trial aims to find out if this treatment helps reduce symptoms and improve heart function.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
528 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You must be between 18 and 80 years old.
  • You need to have symptoms of reduced blood flow to the heart (ischemia), like chest pain, and tests that show this.
  • A coronary angiogram must show a narrowing of more than 50% in one of your heart's major arteries.
  • Special tests (QFR and AMR) must show that the tiny blood vessels in your heart are not working properly.
  • You cannot have taken any Chinese herbal medicines for at least 2 weeks before joining.
  • You must not have severe liver, kidney, or heart problems, or be pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06699420Recruiting· Phase 4
Qishenyiqi pill for small vessel heart disease

This trial tests if a Chinese herbal pill called Qishenyiqi can help people with chest pain caused by tiny heart blood vessels that are too tight. It may be an option if standard tests show your heart vessels are mostly clear but your blood flow is reduced.

Jinan, Shandong
NCT06676137Recruiting
Coronary microvascular disease study in China

This study looks at chest pain caused by tiny blood vessels in the heart that don't show up on standard angiograms. It aims to understand this condition better to help find better care.

Zhengzhou
NCT07041359Recruiting· Phase 4
Traditional Chinese medicine for elderly heart disease patients with ongoing symptoms

This trial tests whether traditional Chinese medicine can help elderly patients with coronary heart disease who still have chest pain or discomfort despite standard treatments. It focuses on those who cannot have or have not fully benefited from procedures like stents or bypass surgery.

Beijing, Beijing Municipality
NCT07445581Not yet recruiting
Herbal medicine for elderly heart attack patients with brain artery narrowing

This study tests a traditional Chinese herbal medicine, Tanhuo Decoction, in elderly patients who have had a recent heart attack and also have narrowed brain arteries. It aims to see if adding this herbal treatment to standard care helps improve their recovery.

Beijing, Beijing Municipality
NCT06425120Recruiting· Phase 4
Xuesaitong for heart disease risk factors

This trial tests whether Xuesaitong soft capsules can improve major risk factors in people with stable coronary heart disease who are already on cholesterol-lowering and antiplatelet medications. You may be able to join if you have chronic coronary artery disease and certain signs of inflammation.

Beijing, Beijing Municipality
NCT06845254Not yet recruiting· Phase 3
Xuesaitong capsules for heart patients after stent procedure

This study tests a Chinese herbal medicine called Xuesaitong soft capsules for people who recently had a heart attack or unstable angina and had a stent placed. The goal is to see if taking these capsules helps improve heart health after the procedure.

Beijing

Hear when a new Coronary Microvascular Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.